1. An in vivo role for Rho kinase activation in the tumour vascular disrupting activity of combretastatin A‐4 3‐O‐phosphate. (November 2014) Authors: Williams, L J; Mukherjee, D; Fisher, M; Reyes‐Aldasoro, C C; Akerman, S; Kanthou, C; Tozer, G M Journal: British journal of pharmacology Issue: Volume 171:Number 21(2014:Nov.) Page Start: 4902 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗